Bisphenol A Exposure Disrupts Genomic Imprinting in the Mouse
Exposure to endocrine disruptors is associated with developmental defects. One compound of concern, to which humans are widely exposed, is bisphenol A (BPA). In model organisms, BPA exposure is linked to metabolic disorders, infertility, cancer, and behavior anomalies. Recently, BPA exposure has been linked to DNA methylation changes, indicating that epigenetic mechanisms may be relevant. We investigated effects of exposure on genomic imprinting in the mouse as imprinted genes are regulated by differential DNA methylation and aberrant imprinting disrupts fetal, placental, and postnatal development. Through allele-specific and quantitative real-time PCR analysis, we demonstrated that maternal BPA exposure during late stages of oocyte development and early stages of embryonic development significantly disrupted imprinted gene expression in embryonic day (E) 9.5 and 12.5 embryos and placentas. The affected genes included Snrpn, Ube3a, Igf2, Kcnq1ot1, Cdkn1c, and Ascl2; mutations and aberrant regulation of these genes are associated with imprinting disorders in humans. Furthermore, the majority of affected genes were expressed abnormally in the placenta. DNA methylation studies showed that BPA exposure significantly altered the methylation levels of differentially methylated regions (DMRs) including the Snrpn imprinting control region (ICR) and Igf2 DMR1. Moreover, exposure significantly reduced genome-wide methylation levels in the placenta, but not the embryo. Histological and immunohistochemical examinations revealed that these epigenetic defects were associated with abnormal placental development. In contrast to this early exposure paradigm, exposure outside of the epigenetic reprogramming window did not cause significant imprinting perturbations. Our data suggest that early exposure to common environmental compounds has the potential to disrupt fetal and postnatal health through epigenetic changes in the embryo and abnormal development of the placenta.
Vyšlo v časopise:
Bisphenol A Exposure Disrupts Genomic Imprinting in the Mouse. PLoS Genet 9(4): e32767. doi:10.1371/journal.pgen.1003401
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1003401
Souhrn
Exposure to endocrine disruptors is associated with developmental defects. One compound of concern, to which humans are widely exposed, is bisphenol A (BPA). In model organisms, BPA exposure is linked to metabolic disorders, infertility, cancer, and behavior anomalies. Recently, BPA exposure has been linked to DNA methylation changes, indicating that epigenetic mechanisms may be relevant. We investigated effects of exposure on genomic imprinting in the mouse as imprinted genes are regulated by differential DNA methylation and aberrant imprinting disrupts fetal, placental, and postnatal development. Through allele-specific and quantitative real-time PCR analysis, we demonstrated that maternal BPA exposure during late stages of oocyte development and early stages of embryonic development significantly disrupted imprinted gene expression in embryonic day (E) 9.5 and 12.5 embryos and placentas. The affected genes included Snrpn, Ube3a, Igf2, Kcnq1ot1, Cdkn1c, and Ascl2; mutations and aberrant regulation of these genes are associated with imprinting disorders in humans. Furthermore, the majority of affected genes were expressed abnormally in the placenta. DNA methylation studies showed that BPA exposure significantly altered the methylation levels of differentially methylated regions (DMRs) including the Snrpn imprinting control region (ICR) and Igf2 DMR1. Moreover, exposure significantly reduced genome-wide methylation levels in the placenta, but not the embryo. Histological and immunohistochemical examinations revealed that these epigenetic defects were associated with abnormal placental development. In contrast to this early exposure paradigm, exposure outside of the epigenetic reprogramming window did not cause significant imprinting perturbations. Our data suggest that early exposure to common environmental compounds has the potential to disrupt fetal and postnatal health through epigenetic changes in the embryo and abnormal development of the placenta.
Zdroje
1. BarkerDJ (1997) Maternal nutrition, fetal nutrition, and disease in later life. Nutrition 13: 807–813.
2. HarrisRM, WaringRH (2012) Diethylstilboestrol-A long-term legacy. Maturitas 72: 108–112.
3. EubigPA, AguiarA, SchantzSL (2010) Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect 118: 1654–1667.
4. MarkhamJA, KoenigJI (2011) Prenatal stress: role in psychotic and depressive diseases. Psychopharmacology (Berl) 214: 89–106.
5. RoseboomTJ, PainterRC, van AbeelenAF, VeenendaalMV, deRooijSR (2011) Hungry in the womb: what are the consequences? Lessons from the Dutch famine. Maturitas 70: 141–145.
6. LillycropKA, Slater-JefferiesJL, HansonMA, GodfreyKM, JacksonAA, et al. (2007) Induction of altered epigenetic regulation of the hepatic glucocorticoid receptor in the offspring of rats fed a protein-restricted diet during pregnancy suggests that reduced DNA methyltransferase-1 expression is involved in impaired DNA methylation and changes in histone modifications. Br J Nutr 97: 1064–1073.
7. TobiEW, LumeyLH, TalensRP, KremerD, PutterH, et al. (2009) DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet 18: 4046–4053.
8. AnwayMD, LeathersC, SkinnerMK (2006) Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 147: 5515–5523.
9. DolinoyDC, HuangD, JirtleRL (2007) Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A 104: 13056–13061.
10. WaterlandRA, JirtleRL (2004) Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20: 63–68.
11. FeinbergAP, TyckoB (2004) The history of cancer epigenetics. Nat Rev Cancer 4: 143–153.
12. ArnaudP, FeilR (2005) Epigenetic deregulation of genomic imprinting in human disorders and following assisted reproduction. Birth Defects Res C Embryo Today 75: 81–97.
13. WeaverJR, SusiarjoM, BartolomeiMS (2009) Imprinting and epigenetic changes in the early embryo. Mamm Genome 20: 532–543.
14. RiveraRM, SteinP, WeaverJR, MagerJ, SchultzRM, et al. (2008) Manipulations of mouse embryos prior to implantation result in aberrant expression of imprinted genes on day 9.5 of development. Hum Mol Genet 17: 1–14.
15. MannMR, LeeSS, DohertyAS, VeronaRI, NolenLD, et al. (2004) Selective loss of imprinting in the placenta following preimplantation development in culture. Development 131: 3727–3735.
16. FortierAL, LopesFL, DarricarrereN, MartelJ, TraslerJM (2008) Superovulation alters the expression of imprinted genes in the midgestation mouse placenta. Hum Mol Genet 17: 1653–1665.
17. Gallou-KabaniC, GaboryA, TostJ, KarimiM, MayeurS, et al. (2010) Sex- and diet-specific changes of imprinted gene expression and DNA methylation in mouse placenta under a high-fat diet. PLoS ONE 5: e14398 doi:10.1371/journal.pone.0014398.
18. de MouzonJ, GoossensV, BhattacharyaS, CastillaJA, FerrarettiAP, et al. (2010) Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod 25: 1851–1862.
19. vom SaalFS, HughesC (2005) An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ Health Perspect 113: 926–933.
20. VandenbergLN, ChahoudI, HeindelJJ, PadmanabhanV, PaumgarttenFJ, et al. (2012) Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol a. Cien Saude Colet 17: 407–434.
21. WelshonsWV, NagelSC, vom SaalFS (2006) Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147: S56–69.
22. HoSM, TangWY, Belmonte de FraustoJ, PrinsGS (2006) Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66: 5624–5632.
23. YaoiT, ItohK, NakamuraK, OgiH, FujiwaraY, et al. (2008) Genome-wide analysis of epigenomic alterations in fetal mouse forebrain after exposure to low doses of bisphenol A. Biochem Biophys Res Commun 376: 563–567.
24. BromerJG, ZhouY, TaylorMB, DohertyL, TaylorHS (2010) Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. Faseb J 24: 2273–2280.
25. BartolomeiMS (2009) Genomic imprinting: employing and avoiding epigenetic processes. Genes Dev 23: 2124–2133.
26. KelseyG (2007) Genomic imprinting–roles and regulation in development. Endocr Dev 12: 99–112.
27. IderaabdullahFY, VigneauS, BartolomeiMS (2008) Genomic imprinting mechanisms in mammals. Mutat Res 647: 77–85.
28. OkaeH, HiuraH, NishidaY, FunayamaR, TanakaS, et al. (2012) Re-investigation and RNA sequencing-based identification of genes with placenta-specific imprinted expression. Hum Mol Genet 21: 548–558.
29. SmallwoodSA, TomizawaS, KruegerF, RufN, CarliN, et al. (2011) Dynamic CpG island methylation landscape in oocytes and preimplantation embryos. Nat Genet 43: 811–814.
30. VeronaRI, MannMR, BartolomeiMS (2003) Genomic imprinting: intricacies of epigenetic regulation in clusters. Annu Rev Cell Dev Biol 19: 237–259.
31. LuciferoD, MertineitC, ClarkeHJ, BestorTH, TraslerJM (2002) Methylation dynamics of imprinted genes in mouse germ cells. Genomics 79: 530–538.
32. ConstanciaM, DeanW, LopesS, MooreT, KelseyG, et al. (2000) Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Nat Genet 26: 203–206.
33. KarimiM, LuttroppK, EkstromTJ (2011) Global DNA methylation analysis using the luminometric methylation assay. Methods Mol Biol 791: 135–144.
34. PoppC, DeanW, FengS, CokusSJ, AndrewsS, et al. (2010) Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463: 1101–1105.
35. BartolomeiMS, Ferguson-SmithAC (2011) Mammalian genomic imprinting. Cold Spring Harb Perspect Biol 3
36. RossantJ, CrossJC (2001) Placental development: lessons from mouse mutants. Nat Rev Genet 2: 538–548.
37. KangER, IqbalK, TranDA, RivasGE, SinghP, et al. (2011) Effects of endocrine disruptors on imprinted gene expression in the mouse embryo. Epigenetics 6: 937–950.
38. HajkovaP, AncelinK, WaldmannT, LacosteN, LangeUC, et al. (2008) Chromatin dynamics during epigenetic reprogramming in the mouse germ line. Nature 452: 877–881.
39. AmorDJ, HallidayJ (2008) A review of known imprinting syndromes and their association with assisted reproduction technologies. Hum Reprod 23: 2826–2834.
40. WuMY, ChenKS, BresslerJ, HouA, TsaiTF, et al. (2006) Mouse imprinting defect mutations that model Angelman syndrome. Genesis 44: 12–22.
41. JirtleRL, SkinnerMK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8: 253–262.
42. SchonfelderG, WittfohtW, HoppH, TalsnessCE, PaulM, et al. (2002) Parent bisphenol A accumulation in the human maternal-fetal-placental unit. Environ Health Perspect 110: A703–707.
43. LewisA, MitsuyaK, UmlaufD, SmithP, DeanW, et al. (2004) Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation. Nat Genet 36: 1291–1295.
44. UmlaufD, GotoY, CaoR, CerqueiraF, WagschalA, et al. (2004) Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes. Nat Genet 36: 1296–1300.
45. WingfieldJC, MukaiM (2009) Endocrine disruption in the context of life cycles: perception and transduction of environmental cues. Gen Comp Endocrinol 163: 92–96.
46. MurphySK, AdigunA, HuangZ, OvercashF, WangF, et al. (2012) Gender-specific methylation differences in relation to prenatal exposure to cigarette smoke. Gene 494: 36–43.
47. HeijmansBT, TobiEW, SteinAD, PutterH, BlauwGJ, et al. (2008) Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 105: 17046–17049.
48. Steegers-TheunissenRP, Obermann-BorstSA, KremerD, LindemansJ, SiebelC, et al. (2009) Periconceptional maternal folic acid use of 400 microg per day is related to increased methylation of the IGF2 gene in the very young child. PLoS ONE 4: e7845 doi:10.1371/journal.pone.0007845.
49. WeksbergR, SmithAC, SquireJ, SadowskiP (2003) Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet 12 Spec No 1: R61–68.
50. DeChiaraTM, EfstratiadisA, RobertsonEJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345: 78–80.
51. LeightonPA, SaamJR, IngramRS, StewartCL, TilghmanSM (1995) An enhancer deletion affects both H19 and Igf2 expression. Genes Dev 9: 2079–2089.
52. WeaverJR, SarkisianG, KrappC, MagerJ, MannMR, et al. (2010) Domain-specific response of imprinted genes to reduced DNMT1. Mol Cell Biol 30: 3916–3928.
53. SieliPT, JasarevicE, WarzakDA, MaoJ, EllersieckMR, et al. (2011) Comparison of serum bisphenol A concentrations in mice exposed to bisphenol A through the diet versus oral bolus exposure. Environ Health Perspect 119: 1260–1265.
54. TachibanaT, WakimotoY, NakamutaN, PhichitraslipT, WakitaniS, et al. (2007) Effects of bisphenol A (BPA) on placentation and survival of the neonates in mice. J Reprod Dev 53: 509–514.
55. TanakaS, OdaM, ToyoshimaY, WakayamaT, TanakaM, et al. (2001) Placentomegaly in cloned mouse concepti caused by expansion of the spongiotrophoblast layer. Biol Reprod 65: 1813–1821.
56. GeorgiadesP, WatkinsM, SuraniMA, Ferguson-SmithAC (2000) Parental origin-specific developmental defects in mice with uniparental disomy for chromosome 12. Development 127: 4719–4728.
57. TunsterSJ, Van de PetteM, JohnRM (2011) Fetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndrome. Dis Model Mech 4: 814–821.
58. ShererDM, AbulafiaO (2001) Angiogenesis during implantation, and placental and early embryonic development. Placenta 22: 1–13.
59. TuuliMG, LongtineMS, NelsonDM (2011) Review: Oxygen and trophoblast biology—a source of controversy. Placenta 32 Suppl 2: S109–118.
60. RodriguezBA, WengYI, LiuTM, ZuoT, HsuPY, et al. (2011) Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells. Carcinogenesis 32: 812–821.
61. TangWY, MoreyLM, CheungYY, BirchL, PrinsGS, et al. (2012) Neonatal Exposure to Estradiol/Bisphenol A Alters Promoter Methylation and Expression of Nsbp1 and Hpcal1 Genes and Transcriptional Programs of Dnmt3a/b and Mbd2/4 in the RatProstate Gland Throughout Life. Endocrinology 153: 42–55.
62. DoshiT, MehtaSS, DigheV, BalasinorN, VanageG (2011) Hypermethylation of estrogen receptor promoter region in adult testis of rats exposed neonatally to bisphenol A. Toxicology 289: 74–82.
63. IvanovaE, KelseyG (2011) Imprinted genes and hypothalamic function. J Mol Endocrinol 47: R67–74.
64. WilkinsJF, UbedaF (2011) Diseases associated with genomic imprinting. Prog Mol Biol Transl Sci 101: 401–445.
65. BraunJM, KalkbrennerAE, CalafatAM, YoltonK, YeX, et al. (2011) Impact of early-life bisphenol A exposure on behavior and executive function in children. Pediatrics 128: 873–882.
66. SathyanarayanaS, BraunJM, YoltonK, LiddyS, LanphearBP (2011) Case report: high prenatal bisphenol a exposure and infant neonatal neurobehavior. Environ Health Perspect 119: 1170–1175.
67. BraunJM, YoltonK, DietrichKN, HornungR, YeX, et al. (2009) Prenatal bisphenol A exposure and early childhood behavior. Environ Health Perspect 117: 1945–1952.
68. Vom SaalFS, NagelSC, CoeBL, AngleBM, TaylorJA (2012) The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol 354: 74–84.
69. RubinBS, SotoAM (2009) Bisphenol A: Perinatal exposure and body weight. Mol Cell Endocrinol 304: 55–62.
70. CantonwineD, MeekerJD, HuH, SanchezBN, Lamadrid-FigueroaH, et al. (2010) Bisphenol a exposure in Mexico City and risk of prematurity: a pilot nested case control study. Environ Health 9: 62.
71. ChouWC, ChenJL, LinCF, ChenYC, ShihFC, et al. (2011) Biomonitoring of bisphenol A concentrations in maternal and umbilical cord blood in regard to birth outcomes and adipokine expression: a birth cohort study in Taiwan. Environ Health 10: 94.
72. MannMRW, ChungYG, NolenLD, VeronaRI, LathamKE, et al. (2003) Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos. Biol Reprod 69: 902–914.
73. DavisTL, TraslerJM, MossSB, YangGJ, BartolomeiMS (1999) Acquisition of the H19 methylation imprint occurs differentially on the parental alleles during spermatogenesis. Genomics 58: 18–28.
74. TremblayKD, DuranKL, BartolomeiMS (1997) A 5′ 2-kilobase-pair region of the imprinted mouse H19 gene exhibits exclusive paternal methylation throughout development. Mol Cell Biol 17: 4322–4329.
75. SinghG, GutierrezA, XuK, BlairIA (2000) Liquid chromatography/electron capture atmospheric pressure chemical ionization/mass spectrometry: analysis of pentafluorobenzyl derivatives of biomolecules and drugs in the attomole range. Anal Chem 72: 3007–3013.
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2013 Číslo 4
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- The G4 Genome
- Neutral Genomic Microevolution of a Recently Emerged Pathogen, Serovar Agona
- The Histone Demethylase Jarid1b Ensures Faithful Mouse Development by Protecting Developmental Genes from Aberrant H3K4me3
- The Tissue-Specific RNA Binding Protein T-STAR Controls Regional Splicing Patterns of Pre-mRNAs in the Brain